The Community Oncology Alliance (COA) meetings featured expert discussions around the evolving landscape of oncology care and ...

Results of a small study presented at the 66th American Society of Hematology Annual Meeting & Exposition suggest combining ...

Martin Dietrich, MD, PhD, discusses how the FDA-approved combination therapy is transforming care for resectable early-stage ...

Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.

The mean body mass index (BMI) and the prevalence of obesity both dropped in 2023 for the first time in more than a decade.

The investigational oral HER2-specific tyrosine kinase inhibitor would address an unmet need in non–small cell lung cancer.

Recent discussions at an Institute for Value-Based Medicine event highlighted the significant potential of biosimilars in ...

Health experts have concluded that COVID-19 can spread among asymptomatic people, making it hard to tell how many people have ...

Connect 2024 emphasized the transformative potential of artificial intelligence (AI) and predictive analytics in addressing ...

The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...

Robin Glasgow, MBA, executive leadership advisor of Spencer Stuart, discusses the critical role of data in health care, ...